Outside experts who advise the government on drugs and other regulated products often have financial ties to industry, creating the potential for conflicts of interest.
(snip)
The FDA says that simply eliminating all outside reviewers with potential conflicts would deny the FDA access to advisers with the expertise and experience it seeks.
`We probably couldn't recruit department chairmen. It would hinder us from recruiting all but junior faculty members,'' Gottlieb said.
(snip)
``It just doesn't make any sense to me. When you have this problem - conflicts of interest on critical panels - the solution is eliminate the conflict. It's simple and easy to do,'' said Rep. Maurice Hinchey, D-N.Y.
http://www.guardian.co.uk/worldlatest/story/0,,-5970228,00.html